GridAI Technologies Corp.
- GRDX
- NASDAQ
- Biotechnology
- Gastrointestinal (GI) Therapeutics
- Clinical-Stage Biotech
$4.59
Today +4.56%Quote Oct 20, 2026, 02:08 PM UTC
+41.16%over the last month
Max drawdown −16.2%From 1-month high −11.7%3 months +24.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About GridAI Technologies
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
2
Market value
$32.7M
Quote Oct 20
Floor
$4.53
1.3% below price
Resistance
$4.77
3.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GRDXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free